Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney

被引:44
|
作者
Ishiguro, N
Saito, A
Yokoyama, K
Morikawa, M
Igarashi, T
Tamai, I
机构
[1] Sci Univ Tokyo, Fac Pharmaceut Sci, Chiba 2788510, Japan
[2] Nippon Boehringer Ingelheim Co Ltd, Kawanishi Pharma Res Inst, Dept Drug Metab & Pharmacokinet, Kawanishi, Hyogo, Japan
关键词
D O I
10.1124/dmd.104.002519
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the mechanism of renal tubular secretion of the dopamine D-2 receptor agonist pramipexole in rats, focusing on organic cation transporters 1 and 2. The uptake of [C-14]pramipexole by Xenopus oocytes injected with complementary RNA of either rat organic cation transporter (rOCT) 1 or rOCT2 was significantly higher than that by water-injected oocytes: the kinetic parameters, K-m and V-max, of pramipexole uptake were 49.5 mu M and 234 pmol/60 min/oocyte for rOCT1, and 16.9 mu M and 12.8 pmol/60 min/oocyte for rOCT2. Pramipexole was taken up into kidney slices in a time- and concentration-dependent manner, and Eadie-Hofstee plots revealed the involvement of two saturable components. The kinetic parameters, K-m1 and V-max1, of the high-affinity component were 12.9 mu M and 10.7 nmol/15 min/g kidney, respectively. The uptake of [C-14]pramipexole by rOCT1, rOCT2, and kidney slices was inhibited by procainamide and corticosterone, which are selective inhibitors of rOCT1 and rOCT2, respectively. The IC50 values of procainamide and corticosterone for the uptake of [C-14]pramipexole by rOCT1, rOCT2, and kidney slices were 7.7, 167.0, and 47.0 mu M and 163.7, 10.7, and 47.7 mu M, respectively. These results demonstrate that both rOCT1 and rOCT2 are involved in the renal uptake of pramipexole across the basolateral membrane of the proximal tubular epithelial cells.
引用
收藏
页码:495 / 499
页数:5
相关论文
共 50 条
  • [1] Localization of organic cation transporters OCT1 and OCT2 in rat kidney
    Karbach, U
    Kricke, J
    Meyer-Wentrup, F
    Gorboulev, V
    Volk, C
    Loffing-Cueni, D
    Kaissling, B
    Bachmann, S
    Koepsell, H
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (04) : F679 - F687
  • [2] Polyamine Transport by the Polyspecific Organic Cation Transporters OCT1, OCT2, and OCT3
    Sala-Rabanal, Monica
    Li, Dan C.
    Dake, Gregory R.
    Kurata, Harley T.
    Inyushin, Mikhail
    Skatchkov, Serguei N.
    Nichols, Colin G.
    MOLECULAR PHARMACEUTICS, 2013, 10 (04) : 1450 - 1458
  • [3] The organic cation transporters OCT1 and OCT2 contain an allosteric cation inhibitor site.
    Koepsell, H
    UlzheimerTeuber, I
    Ulzheimer, J
    Arndt, P
    Gorboulev, V
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0259 - A0259
  • [4] Inhibition of the organic cation transporters OCT1 and OCT2 by drugs frequently used in psychiatry
    Muench, K.
    Maas, R.
    Zolk, O.
    Fromm, M. F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 28 - 29
  • [5] INHIBITION OF THE ORGANIC CATION TRANSPORTERS OCT1 AND OCT2 BY 100 FREQUENTLY PRESCRIBED DRUGS
    Muench, K.
    Zolk, O.
    Maas, R.
    Fromm, M. F.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 : 4 - 4
  • [6] TRANSPORT OF L-ARGININE AND ASYMMETRIC DIMETHYLARGININE (ADMA) BY HUMAN ORGANIC CATION TRANSPORTERS 1 AND 2 (OCT1 AND OCT2)
    Strobel, J.
    Zolk, O.
    Mueller, F.
    Koenig, J.
    Fromm, M. F.
    Maas, R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 : 29 - 29
  • [7] Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules
    Urakami, Y
    Okuda, M
    Masuda, S
    Akazawa, M
    Saito, H
    Inui, K
    PHARMACEUTICAL RESEARCH, 2001, 18 (11) : 1528 - 1534
  • [8] Distinct Characteristics of Organic Cation Transporters, OCT1 and OCT2, in the Basolateral Membrane of Renal Tubules
    Yumiko Urakami
    Masahiro Okuda
    Satohiro Masuda
    Maiko Akazawa
    Hideyuki Saito
    Ken-ich Inui
    Pharmaceutical Research, 2001, 18 : 1528 - 1534
  • [9] Inhibitory interaction of 125 frequently prescribed drugs with the organic cation transporters OCT1 and OCT2
    Muench, K.
    Zolk, O.
    Monti, J.
    Maas, R.
    Fromm, M. F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S58 - S58
  • [10] The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
    Tzvetkov, M. V.
    Vormfelde, S. V.
    Balen, D.
    Meineke, I.
    Schmidt, T.
    Sehrt, D.
    Sabolic, I.
    Koepsell, H.
    Brockmoeller, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (03) : 299 - 306